82_FR_62015 82 FR 61766 - Meeting of the Advisory Committee on Minority Health [email protected] Information about the meeting is available from the designated contact and will be posted on the website for the Office of Minority Health (OMH), www.minorityhealth.hhs.gov. Information about ACMH activities can be found on the OMH website under the heading About OMH."> [email protected] Information about the meeting is available from the designated contact and will be posted on the website for the Office of Minority Health (OMH), www.minorityhealth.hhs.gov. Information about ACMH activities can be found on the OMH website under the heading About OMH." /> [email protected] Information about the meeting is available from the designated contact and will be posted on the website for the Office of Minority Health (OMH), www.minorityhealth.hhs.gov. Information about ACMH activities can be found on the OMH website under the heading About OMH." />

82 FR 61766 - Meeting of the Advisory Committee on Minority Health

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 82, Issue 249 (December 29, 2017)

Page Range61766-61766
FR Document2017-28161

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the Advisory Committee on Minority Health (ACMH) will hold a meeting. This meeting will be open to the public. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meetings and/or participate in the public comment session should email [email protected] Information about the meeting is available from the designated contact and will be posted on the website for the Office of Minority Health (OMH), www.minorityhealth.hhs.gov. Information about ACMH activities can be found on the OMH website under the heading About OMH.

Federal Register, Volume 82 Issue 249 (Friday, December 29, 2017) 
[Federal Register Volume 82, Number 249 (Friday, December 29, 2017)]
[Notices]
[Page 61766]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-28161]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Advisory Committee on Minority Health

AGENCY: Office of Minority Health, Office of the Secretary, Department 
of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Advisory Committee on Minority Health (ACMH) will hold a 
meeting. This meeting will be open to the public. Preregistration is 
required for both public attendance and comment. Any individual who 
wishes to attend the meetings and/or participate in the public comment 
session should email [email protected]. Information about the meeting is 
available from the designated contact and will be posted on the website 
for the Office of Minority Health (OMH), www.minorityhealth.hhs.gov. 
Information about ACMH activities can be found on the OMH website under 
the heading About OMH.

DATES: The meeting will be held on Monday, March 26, 2018, from 9:00 
a.m. to 5:00 p.m. and Tuesday, March 27, 2018, from 9:00 a.m. to 1:00 
p.m.

ADDRESSES: The meeting will be held at the 5600 Fishers Lane Building, 
Room 05E29, 5600 Fishers Lane, Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: Dr. Minh Wendt, Designated Federal 
Officer, Advisory Committee on Minority Health, Office of Minority 
Health, Department of Health and Human Services, Tower Building, 1101 
Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240-453-
8222; fax: 240-453-8223; email [email protected].

SUPPLEMENTARY INFORMATION: In accordance with Public Law 105-392, the 
ACMH was established to provide advice to the Deputy Assistant 
Secretary for Minority Health on improving the health of each racial 
and ethnic minority group and on the development of goals and specific 
program activities of the OMH.
    The topics to be discussed during this meeting will include 
strategies to improve the health of racial and ethnic minority 
populations through the development of health policies and programs 
that will help eliminate health disparities with an emphasis on serious 
mental illness. The recommendations will be given to the Deputy 
Assistant Secretary for Minority Health.
    Public attendance at this meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the designated contact person at least fourteen (14) business 
days prior to the meeting. Members of the public will have an 
opportunity to provide comments at the meeting. Public comments will be 
limited to three minutes per speaker. Individuals who would like to 
submit written statements should mail or fax their comments to the 
Office of Minority Health at least seven (7) business days prior to the 
meeting. Any members of the public who wish to have printed material 
distributed to ACMH committee members should submit their materials to 
the Designated Federal Officer, ACMH, Tower Building, 1101 Wootton 
Parkway, Suite 600, Rockville, Maryland 20852, prior to close of 
business on Monday, March 19, 2018.

    Dated: December 22, 2017.
Minh Wendt,
Designated Federal Officer, Advisory Committee on Minority Health.
[FR Doc. 2017-28161 Filed 12-28-17; 8:45 am]
 BILLING CODE 4150-29-P

61766 Federal Register / Vol. 82, No. 249 / Friday, December 29, 2017 / Notices under control number 0910–0014. The DEPARTMENT OF HEALTH AND Public attendance at this meeting is information collection described in the HUMAN SERVICES limited to space available. Individuals guidance for industry entitled ‘‘Formal who plan to attend and need special Meetings Between the FDA and Meeting of the Advisory Committee on assistance, such as sign language Sponsors or Applicants of PDUFA Minority Health interpretation or other reasonable Products’’ is approved by OMB under AGENCY: Office of Minority Health, accommodations, should notify the control number 0910–0429. The Office of the Secretary, Department of designated contact person at least information collection described in the Health and Human Services. fourteen (14) business days prior to the guidance for industry entitled ‘‘Formal meeting. Members of the public will ACTION: Notice of meeting. Dispute Resolution: Sponsor Appeals have an opportunity to provide Above the Division Level’’ (available at SUMMARY: As stipulated by the Federal comments at the meeting. Public https://www.fda.gov/downloads/Drugs/ Advisory Committee Act, the comments will be limited to three Department of Health and Human minutes per speaker. Individuals who GuidanceComplianceRegulatory Services (HHS) is hereby giving notice would like to submit written statements Information/Guidances/ that the Advisory Committee on should mail or fax their comments to UCM343101.pdf) is approved by OMB the Office of Minority Health at least Minority Health (ACMH) will hold a under control number 0910–0430. The meeting. This meeting will be open to seven (7) business days prior to the information collection described in the the public. Preregistration is required meeting. Any members of the public ‘‘Evaluation of the Program for for both public attendance and who wish to have printed material Enhanced Review Transparency and comment. Any individual who wishes distributed to ACMH committee Communication for New Molecular to attend the meetings and/or members should submit their materials Entity New Drug Applications and participate in the public comment to the Designated Federal Officer, Original Biologics License Applications session should email OMH-ACMH@ ACMH, Tower Building, 1101 Wootton in Prescription Drug User Fee Acts’’ is hhs.gov. Information about the meeting Parkway, Suite 600, Rockville, approved by OMB under control is available from the designated contact Maryland 20852, prior to close of number 0910–0746. The information and will be posted on the website for business on Monday, March 19, 2018. collection described in the guidance for the Office of Minority Health (OMH), Dated: December 22, 2017. industry entitled ‘‘Expedited Programs www.minorityhealth.hhs.gov. Minh Wendt, for Serious Conditions—Drugs and Information about ACMH activities can be found on the OMH website under the Designated Federal Officer, Advisory Biologics’’ (available at https:// Committee on Minority Health. www.fda.gov/downloads/Drugs/ heading About OMH. [FR Doc. 2017–28161 Filed 12–28–17; 8:45 am] GuidanceComplianceRegulatory DATES: The meeting will be held on BILLING CODE 4150–29–P Information/Guidances/ Monday, March 26, 2018, from 9:00 a.m. UCM358301.pdf) is approved by OMB to 5:00 p.m. and Tuesday, March 27, under control number 0910–0765. The 2018, from 9:00 a.m. to 1:00 p.m. DEPARTMENT OF HEALTH AND information collection described in the ADDRESSES: The meeting will be held at HUMAN SERVICES guidance for industry entitled ‘‘Formal the 5600 Fishers Lane Building, Room Meetings Between the FDA and 05E29, 5600 Fishers Lane, Rockville, National Institutes of Health Biosimilar Biological Product Sponsors Maryland 20857. or Applicants’’ (available at https:// FOR FURTHER INFORMATION CONTACT: Dr. National Institute of Allergy and www.fda.gov/downloads/Drugs/ Minh Wendt, Designated Federal Infectious Diseases; Notice of Closed GuidanceComplianceRegulatory Officer, Advisory Committee on Meetings Minority Health, Office of Minority Information/Guidances/ Health, Department of Health and Pursuant to section 10(d) of the UCM345649.pdf) is approved by OMB Federal Advisory Committee Act, as Human Services, Tower Building, 1101 under control number 0910–0802. Wootton Parkway, Suite 600, Rockville, amended, notice is hereby given of the III. Electronic Access Maryland 20852. Phone: 240–453–8222; following meetings. fax: 240–453–8223; email OMH-ACMH@ The meetings will be closed to the Persons with access to the internet hhs.gov. public in accordance with the may obtain the guidance at https:// SUPPLEMENTARY INFORMATION: In provisions set forth in sections www.fda.gov/Drugs/Guidance accordance with Public Law 105–392, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., ComplianceRegulatoryInformation/ the ACMH was established to provide as amended. The grant applications and Guidances/default.htm, https:// advice to the Deputy Assistant Secretary the discussions could disclose www.fda.gov/BiologicsBloodVaccines/ for Minority Health on improving the confidential trade secrets or commercial GuidanceComplianceRegulatory health of each racial and ethnic property such as patentable material, Information/default.htm, or https:// minority group and on the development and personal information concerning www.regulations.gov. of goals and specific program activities individuals associated with the grant Dated: December 19, 2017. of the OMH. applications, the disclosure of which The topics to be discussed during this would constitute a clearly unwarranted Leslie Kux, meeting will include strategies to invasion of personal privacy. Associate Commissioner for Policy. improve the health of racial and ethnic ethrower on DSK3G9T082PROD with NOTICES Name of Committee: National Institute of [FR Doc. 2017–28139 Filed 12–28–17; 8:45 am] minority populations through the Allergy and Infectious Diseases Special BILLING CODE 4164–01–P development of health policies and Emphasis Panel; AIDS Research Review programs that will help eliminate health Committee (AIDSRRC) Independent SEP. disparities with an emphasis on serious Date: January 18, 2018. mental illness. The recommendations Time: 1:00 p.m. to 2:00 p.m. will be given to the Deputy Assistant Agenda: To review and evaluate grant Secretary for Minority Health. applications. VerDate Sep<11>2014 20:09 Dec 28, 2017 Jkt 244001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1


Document Created: 2018-01-03 13:16:39
Document Modified: 2018-01-03 13:16:39
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting.
DatesThe meeting will be held on Monday, March 26, 2018, from 9:00 a.m. to 5:00 p.m. and Tuesday, March 27, 2018, from 9:00 a.m. to 1:00 p.m.
ContactDr. Minh Wendt, Designated Federal Officer, Advisory Committee on Minority Health, Office of Minority Health, Department of Health and Human Services, Tower Building, 1101 Wootton Parkway, Suite 600, Rockville, Maryland 20852. Phone: 240-453- 8222; fax: 240-453-8223; email [email protected]
FR Citation82 FR 61766 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR